106 related articles for article (PubMed ID: 26547551)
1. Glucose lowering effect of montbretin A in Zucker Diabetic Fatty rats.
Yuen VG; Coleman J; Withers SG; Andersen RJ; Brayer GD; Mustafa S; McNeill JH
Mol Cell Biochem; 2016 Jan; 411(1-2):373-81. PubMed ID: 26547551
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of the anti-diabetic metabolite montbretin A: glucosylation of the central intermediate mini-MbA.
Irmisch S; Jancsik S; Yuen MMS; Madilao LL; Bohlmann J
Plant J; 2019 Dec; 100(5):879-891. PubMed ID: 31400245
[TBL] [Abstract][Full Text] [Related]
3. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
4. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule.
Wright BE; Vasselli JR; Katovich MJ
Physiol Behav; 1998 Mar; 63(5):867-74. PubMed ID: 9618010
[TBL] [Abstract][Full Text] [Related]
5. Improved production of the antidiabetic metabolite montbretin A in Nicotiana benthamiana: discovery, characterization, and use of Crocosmia shikimate shunt genes.
Kruse LH; Sunstrum FG; Garcia D; López Pérez G; Jancsik S; Bohlmann J; Irmisch S
Plant J; 2024 Feb; 117(3):766-785. PubMed ID: 37960967
[TBL] [Abstract][Full Text] [Related]
6. 4-Coumaroyl-CoA ligases in the biosynthesis of the anti-diabetic metabolite montbretin A.
Sunstrum FG; Liu HL; Jancsik S; Madilao LL; Bohlmann J; Irmisch S
PLoS One; 2021; 16(10):e0257478. PubMed ID: 34618820
[TBL] [Abstract][Full Text] [Related]
7. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats.
Wasan KM; Zamfir C; Pritchard PH; Pederson RA
J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378
[TBL] [Abstract][Full Text] [Related]
8. Effects of insulin and acarbose alone and in combination in the female streptozotocin-induced diabetic rat.
Katovich MJ; Meldrum MJ
J Pharm Sci; 1993 Dec; 82(12):1209-13. PubMed ID: 8308697
[TBL] [Abstract][Full Text] [Related]
9. Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats.
Vasselli JR; Haraczkiewicz E; Maggio CA; Greenwood MR
Pharmacol Biochem Behav; 1983 Jul; 19(1):85-95. PubMed ID: 6622510
[TBL] [Abstract][Full Text] [Related]
10. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats.
Yamashita K; Sugawara S; Sakairi I
Horm Metab Res; 1984 Apr; 16(4):179-82. PubMed ID: 6373545
[TBL] [Abstract][Full Text] [Related]
11. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
Dyrskog SE; Jeppesen PB; Colombo M; Abudula R; Hermansen K
Metabolism; 2005 Sep; 54(9):1181-8. PubMed ID: 16125530
[TBL] [Abstract][Full Text] [Related]
12. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
Madar Z; Melamed EC; Zimlichman R
Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
[TBL] [Abstract][Full Text] [Related]
13. Hyperinsulinemia and smooth muscle cell proliferation.
Ridray S
Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S39-51. PubMed ID: 7550537
[TBL] [Abstract][Full Text] [Related]
14. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
15. Alterations of antioxidant biomarkers and type I collagen deposition in the parotid gland of streptozotocin-induced diabetic rats.
Deconte SR; Oliveira RJ; Calábria LK; Oliveira VN; Gouveia NM; Moraes Ada S; Espindola FS
Arch Oral Biol; 2011 Aug; 56(8):744-51. PubMed ID: 21310393
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term treatment with insulin and/or acarbose on glomerular basement membrane thickening in alloxan-diabetic rats.
Macedo CS; Silva MD; Spadella CT; Breim LC; Capeletti S; Mercadante MC; Hernandes D; Macedo AR
Braz J Med Biol Res; 1996 Oct; 29(10):1329-35. PubMed ID: 9181105
[TBL] [Abstract][Full Text] [Related]
17. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of acarbose on daily plasma glucose profile and cataract development in sand rats.
Madar Z; Hazan A; Pollack A
Eye (Lond); 1994; 8 ( Pt 3)():353-6. PubMed ID: 7958047
[TBL] [Abstract][Full Text] [Related]
19. Complete Biosynthesis of the Anti-Diabetic Plant Metabolite Montbretin A.
Irmisch S; Jancsik S; Man Saint Yuen M; Madilao LL; Bohlmann J
Plant Physiol; 2020 Sep; 184(1):97-109. PubMed ID: 32647038
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of acarbose in normal and diabetic rats: long- and short-term administration.
Hess ME; Haugaard N; Min W; Torbati A
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):163-76. PubMed ID: 3800510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
